Kantonsspital St.Gallen


Stephan Brand, Jolijn Smolders & Claudia Krieger Grübel

abstract A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-
Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
type of project clinical studies
status ongoing - recruiting phase
start of project 2019
end of project 2022
responsible person Prof. Dr. Stephan Brand